The “doctor-recommended” therapy killing thousands of heart patients every year

Here’s a better, SAFER way to ward off heart disease

It’s rare when the American Heart Association (AHA) comes out with guidance that doesn’t make me roll my eyes. But yes, occasionally, it does happen. Though usually, far too late—and almost never without some groan-worthy catch.

Case in point: The AHA’s recent announcement that they no longer recommend aspirin therapy for heart attack prevention. Which comes not a moment too soon… but unfortunately doesn’t give the risks involved with this long-standing recommendation half the urgency they deserve.

A not-so-harmless preventative

First, a little background on why doctors prescribe aspirin in the first place: It’s a blood thinner, which means it keeps blood from clotting.

Blood clots in narrowed vessels and arteries can block blood flow to the heart, causing a heart attack. So the idea is that taking a blood thinner (like aspirin) will keep blood flowing and prevent clots from forming.

But the problem is, blood thinners carry their own risks—including internal bleeding. And they’re especially risky for older adults. Studies show that people over the age of 75 who take aspirin face up to ten times greater risk of developing a fatal or debilitating bleed when compared to younger people.

The fact is, the very thing that’s supposed to make aspirin effective in heart attack prevention is what makes it so dangerous. We need our blood to clot. That’s what keeps us from bleeding uncontrollably when we fall, get into an accident, or have internal bleeding.

I’ve always been a firm believer that if aspirin had to be approved as a medication today, it probably wouldn’t pass the tests. But because it’s been in use for so long—Bayer started selling it in 1899—many in the medical establishment have assumed it’s harmless.

That’s why I was so happy when studies on aspirin’s risks really started to pour in—so more people can learn the truth. And according to the latest research estimates, the truth is that it causes around 20,000 bleeds and more than 3,000 deaths a year.1

This would be shocking enough if aspirin actually did what it was “supposed” to do—prevent heart attacks. But unfortunately, that’s simply not the case, either.

An aspirin a day won’t keep the doctor away

Last year saw the publication of the Aspirin to Reduce Risk of Initial Vascular Events (ARRIVE) trial. It started a decade ago, with the goal of evaluating whether aspirin protects the hearts of subjects with moderate cardiovascular disease risk.

Ultimately, it found that a daily dose of 100 mg of aspirin didn’t lower long-term risk of cardiovascular events. And over an average of five years, roughly the same percentage of subjects in both the placebo and aspirin groups suffered heart disease death, heart attack, angina, stroke, or transient ischemic attack.2

We’re not talking about a small study either. This trial included more than 12,000 nondiabetic adults—all with an array of cardiovascular risk factors, but with no actual history of cardiovascular events. (In other words, exactly the types of patients who would be strongly urged to start popping a daily pill.)

But it’s not that aspirin didn’t do anything. It just didn’t do anything good. Because as you might expect, researchers found that aspirin therapy doubled the rates of gastrointestinal bleeding.

And that’s just the findings from one study. Two more studies published earlier this year really hammer the nails into the coffin…

Useless for 80 percent of the population

Let’s start with a study that was recently published in the Lancet, which suggests that prescribing a standard daily dose of aspirin doesn’t benefit everyone in the same way. In fact, researchers found that the heart benefits of a low dose of 75 to 100 mg of aspirin daily were pretty well confined to people weighing less than 154 pounds.

In this study, most men—some 80 percent of whom weighed over 154 pounds—experienced no clear benefit from aspirin therapy.3

Not to mention the most obvious problem of all: How many American men weigh 154 pounds or less? While the diabesity epidemic rages on, I can’t imagine there are many…

But the real shocker came when researchers looked at the disadvantages of aspirin therapy. Because that’s when they found that subjects on aspirin who weighed less than 154 pounds also faced some very serious health risks—including higher rates of early cancer. Especially if they were older than 70.

This is the most notable finding. Because while plenty of research has looked at aspirin’s pharmacological effects over the years, there are still plenty of questions about how well our bodies tolerate it as we grow older.

These results finally point to an answer—and it’s not exactly encouraging. And neither are the results from the next study I want to share today...

Potentially deadly for patients over 70

A combined Australian-U.S. trial, called ASPREE, was published in the New England Journal of Medicine.

Like the Lancet study, this one looked at elderly patients aged 70 and older, who randomly received either low-dose aspirin (in this case, 100 mg) or a placebo. And like the Lancet study, the results weren’t good.

In fact, it showed that among these elderly patients, low-dose aspirin delivered no benefit—only harm. Primarily in the form of higher rates of cancer.4

Put down the aspirin, and do this instead

Now, with so much research showing just how dangerous daily aspirin therapy really is, you may be wondering why it took the AHA this long to reverse their recommendations and advise against the broad use of aspirin therapy… and you’re not alone.

Meanwhile, even with this change of heart from the AHA, there are still millions of people taking low-dose aspirin around the world as I write this. You might even be one of them.

But believe it or not, the AHA even goes so far as to say that most cases of heart disease are preventable with simple lifestyle modifications—something I could have told them decades ago.

The fact is, my Ultimate Heart-Protection Protocol is the only weapon you need in this fight, as it provides you with an all-natural plan to prevent and reverse America’s biggest killers—high blood pressure, heart attack and stroke. To learn more, or to enroll today, click here or call 1-866-747-9421 and refer to order code EOV3VB03.

Targeted supplementation can also take that protection to the next level, delivering all of the supposed benefits that put aspirin in the spotlight in the first place… without any of the life-threatening risks. So take a look below for my supplement recommendations!

My three all-natural aspirin alternatives

For the record, I do think people should always carry one or two aspirin around with them, just in case they experience chest pains or other signs of heart attack. Because in that instance—and that instance ONLY—aspirin can be life-saving.

But outside of this type of emergency, aspirin is best avoided at all costs—especially on a daily basis. Because the truth is, there are so many safe, natural nutritional supplements you can take as an alternative to help keep your blood cells “slippery” and flowing through your veins and arteries with ease. Here are my top picks:

French maritime pine tree bark extract—50 to 100 mg per day.

This is on the top of my alternative recommendation list because it supports a critical body system frequently overlooked by mainstream medicine—your microcirculation.

This is the vast network of capillaries and small blood vessels that deliver oxygen throughout your body. French maritime pine tree bark extract supports this system by promoting collagen and elastin, which are the main building blocks of blood vessels and capillaries.

Microcirculation is an integral part of whole-body health. Which explains why French maritime pine tree bark extract works so well for so many different health issues—from heart disease, to allergies and asthma, to preventing blood clots on long airplane rides.

Vitamin E—400 to 1,200 IU per day.

This is an oldie but goodie. Our essential enzyme systems need this antioxidant in order to work efficiently—and it also happens to be a powerful blood thinner.

But buyer beware: The vitamin E supplement you use must be natural (make sure it doesn’t have a “dl” prefix listed before the tocopherols), and it must have the full range of tocopherols (alpha, beta, gamma, and delta).

Nattokinase—1,000 to 3,000 fibrin units per day (3,000 fibrin units equals roughly 150 mg).

Last but not least, we have an extract derived from Japanese fermented soybeans—and, simply put, it’s the best natural blood thinner there is.

You can find all of the supplements I’ve recommended here today at your local vitamin shop.

References:

1. Li L, et al. “Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study.” Lancet. 2017 Jul 29;390(10093):490-499.

2. Gaziano JM, et al. “Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial.” Lancet. 2018 Sep 22;392(10152):1036-1046.

3. Rothwell PM, et al. “Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials.” Lancet. 2018 Aug 4;392(10145):387-399.

4. McNeil JJ, et al. “Effect of Aspirin on All-Cause Mortality in the Healthy Elderly.” N Engl J Med. 2018 Oct 18;379(16):1519-1528.


CLOSE
CLOSE